INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 413m ago
House PTR13m ago
SEC 13F12m ago
Robinhood Chain12m ago

Results

10,692 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
55
BP
Boswell PeytonDirector
LIQTLIQTECH INTERNATIONAL INC
Open-market purchase
BUY$50K
50.0K sh
Jun 5, 2026Oct 22, 2026
Page 29 of 268
← PrevNext →
traded Jun 5, 2026
+139d
SEC Form 4

Evidence

50
SR
Sekido RyojiCo-CEO Asia Pacific
ACNAccenture plc
Open-market sale
SELL$270K
1,102 sh
Oct 22, 2026Oct 22, 2026
traded Oct 22, 2026
+0dSEC Form 4

Evidence

47
Darrell IssaRSelf
UCUS Treasury Note 3.375% due 09/15/28 CUSIP 91282CNY3
Purchase
BUY$5.00M – $25.00MOct 8, 2026Oct 22, 2026
traded Oct 8, 2026
+14dHouse PTR

Evidence

43
Darrell IssaRSelf
UCUS Treasury Note 3.375% due 09/15/28 CUSIP 91282CNY3
Sale
SELL$5.00M – $25.00MOct 14, 2026Oct 22, 2026
traded Oct 14, 2026
+8dHouse PTR

Evidence

40
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.09M
5,973 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

40
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.17M
6,487 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$44K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

37
ER
Epstein David RDirector
AGMBAgomAb Therapeutics NV
Open-market purchase
BUY$45K
5,000 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

36
AA
Alan ArmstrongRJoint
WMBWILLIAMS COMPANIES, INC.
Sale (Full)
SELL$250K – $500KSep 8, 2026Oct 22, 2026
traded Sep 8, 2026
+44dSenate PTR

Evidence

36
HB
Harrison David BenjaminPresident, Industries
INTAIntapp, Inc.
Open-market sale · 10b5-1 plan
SELL$1.82M
40.3K sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

34
NL
Newman Randy LDirector
ALRSALERUS FINANCIAL CORP
Gift
G—
89.9K sh
Sep 22, 2026Oct 22, 2026
traded Sep 22, 2026
+30dSEC Form 4

Evidence

34
KA
Kumar AmitDirector, Chief Executive Officer
ANIXAnixa Biosciences Inc
Open-market purchase
BUY$22K
8,000 sh
Oct 22, 2026Oct 22, 2026
traded Oct 22, 2026
+0dSEC Form 4

Evidence

34
MD
Monte Mark DavidDirector
NONENONEFundrise Real Estate Interval Fund, LLC
Open-market purchase
BUY$205
17 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

33
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$637K
3,538 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

32
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.00M
5,514 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

32
DK
Duda KennethDirector, President and CTO
ANETArista Networks, Inc.
Open-market sale · 10b5-1 plan
SELL$1.08M
5,988 sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

31
Saba Capital Management, L.P.10% Owner
MXFMEXICO EQUITY & INCOME FUND INC
Open-market purchase
BUY$327K
16.0K sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

31
Saba Capital Management, L.P.10% Owner
LEOBNY MELLON STRATEGIC MUNICIPALS, INC.
Open-market purchase
BUY$263K
45.8K sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

31
PL
Patterson Kathleen L.Chief HR & Corp Citizenship
ALLYAlly Financial Inc.
Open-market sale
SELL$496K
12.8K sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

30
BW
Booth Richard WhitakerSee Explanation of Responses
NONENONEFundrise Real Estate Interval Fund, LLC
Open-market purchase
BUY$500
42 sh
Oct 21, 2026Oct 22, 2026
traded Oct 21, 2026
+1dSEC Form 4

Evidence

30
PL
Patterson Kathleen L.Chief HR & Corp Citizenship
ALLYAlly Financial Inc.
Tax withholding
F$1.18M
31.0K sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

30
Sweet Julie SpellmanDirector, Chair and CEO
ACNAccenture plc
Tax withholding
F$4.52M
18.8K sh
Oct 20, 2026Oct 22, 2026
traded Oct 20, 2026
+2dSEC Form 4

Evidence

50
KR
Kelly Jason RDirector, See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$463K
45.7K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

46
ZS
Ziegler Christoph SamuelDirector
VRXAVeraxa Biotech AG - Post de-SPAC
Open-market purchase
BUY$33K
30.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

44
BJ
Bradshaw JoshuaDirector, Vice Chairman and President
CLMCornerstone Strategic Investment Fund, Inc.
Open-market purchase
BUY$97K
16.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

44
BJ
Bradshaw JoshuaDirector, Vice Chairman and President
CRFCORNERSTONE TOTAL RETURN FUND INC
Open-market purchase
BUY$118K
20.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

39
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$191K
18.8K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

39
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$191K
18.8K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

39
KR
Kamfar RaminDirector
BPREBluerock Private Real Estate Fund
Open-market purchase
BUY$1.41M
114.9K sh
Oct 21, 2026Oct 21, 2026
traded Oct 21, 2026
+0dSEC Form 4

Evidence

39
KR
Kamfar RaminDirector
BPREBluerock Private Real Estate Fund
Open-market purchase
BUY$1.14M
92.0K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

36
KR
Kamfar RaminDirector
BPREBluerock Private Real Estate Fund
Open-market purchase
BUY$793K
64.7K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

35
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$227K
22.4K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

35
John BoozmanRJoint
IEFiShares 7-10 Year Treasury Bond ETF
Purchase
BUY$1,001 – $15KSep 9, 2026Oct 21, 2026
traded Sep 9, 2026
+42dSenate PTR

Evidence

35
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$227K
22.4K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

34
John BoozmanRJoint
MUMICRON TECHNOLOGY INC
Sale (Partial)
SELL$1,001 – $15KSep 9, 2026Oct 21, 2026
traded Sep 9, 2026
+42dSenate PTR

Evidence

32
AM
ADAR1 Capital Management, LLC10% Owner
TENXTENAX THERAPEUTICS, INC.
Open-market purchase
BUY$507K
336.5K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

32
CP
Coen Steven P.See remarks
DNAGinkgo Bioworks Holdings, Inc.
Open-market sale
SELL$7,770
766 sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

32
Slootman FrankDirector
SNOWSnowflake Inc.
Open-market sale · 10b5-1 plan
SELL$26.16M
82.4K sh
Oct 19, 2026Oct 21, 2026
traded Oct 19, 2026
+2dSEC Form 4

Evidence

31
MM
Magnani Alexandre MrDirector
PAGSPagSeguro Digital Ltd.
Open-market sale
SELL$528K
47.1K sh
Oct 20, 2026Oct 21, 2026
traded Oct 20, 2026
+1dSEC Form 4

Evidence

31
John BoozmanRJoint
SPYMTradr 2X Long SPY Monthly ETF
Sale (Partial)
SELL$1,001 – $15KSep 9, 2026Oct 21, 2026
traded Sep 9, 2026
+42dSenate PTR

Evidence